Capital Fund Management S.A. Novo Nordisk A S Transaction History

Capital Fund Management S.A.

$33.5 Billion
Q1 2025

A detailed history of Capital Fund Management S.A. transactions in Novo Nordisk A S stock. As of the latest transaction made, Capital Fund Management S.A. holds 741,731 shares of NVO stock, worth $40 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

741,731

Previous 724,350 2.4%

Holding current value

$40 Million

Previous $62.3 Million 17.34%

% of portfolio

0.15%

Previous 0.16%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$69.3 - $90.95 $1.2 Million - $1.58 Million	17,381 Added 2.4%	741,731 $51.5 Million
Q4 2024 Feb 13, 2025	BUY	$85.0 - $120.04 $20.2 Million - $28.6 Million	237,950 Added 48.92%	724,350 $62.3 Million
Q3 2024 Nov 13, 2024	BUY	$119.07 - $145.42 $7.79 Million - $9.51 Million	65,390 Added 15.53%	486,400 $57.9 Million
Q2 2024 Aug 13, 2024	SELL	$122.71 - $146.91 $42.7 Million - $51.1 Million	-348,006 Reduced 45.25%	421,010 $60.1 Million
Q1 2024 May 15, 2024	BUY	$102.11 - $135.92 $24.9 Million - $33.1 Million	243,565 Added 46.35%	769,016 $98.7 Million
Q4 2023 Feb 14, 2024	BUY	$87.78 - $105.45 $27.3 Million - $32.7 Million	310,478 Added 144.43%	525,451 $54.4 Million
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $19.5 Million - $42.9 Million	214,973 New	214,973 $19.5 Million
Q3 2022 Nov 14, 2022	SELL	$95.28 - $116.93 $2.57 Million - $3.15 Million	-26,976 Reduced 70.68%	11,189 $1.11 Billion
Q2 2022 Aug 12, 2022	BUY	$103.24 - $121.81 $2.88 Million - $3.4 Million	27,925 Added 272.71%	38,165 $4.25 Million
Q1 2022 May 12, 2022	SELL	$93.1 - $112.54 $234,612 - $283,600	-2,520 Reduced 19.75%	10,240 $1.14 Million
Q3 2021 Nov 12, 2021	BUY	$84.42 - $106.62 $26,423 - $33,372	313 Added 2.51%	12,760 $1.23 Million
Q2 2021 Aug 12, 2021	SELL	$67.66 - $84.76 $20,636 - $25,851	-305 Reduced 2.39%	12,447 $1.04 Million
Q1 2021 May 14, 2021	SELL	$67.06 - $75.82 $13,412 - $15,163	-200 Reduced 1.54%	12,752 $859,000
Q4 2020 Feb 12, 2021	SELL	$63.89 - $73.8 $770,960 - $890,544	-12,067 Reduced 48.23%	12,952 $904,000
Q3 2020 Nov 13, 2020	SELL	$63.69 - $70.22 $125,023 - $137,841	-1,963 Reduced 7.28%	25,019 $1.74 Million
Q2 2020 Aug 13, 2020	SELL	$58.54 - $67.94 $7.25 Million - $8.42 Million	-123,882 Reduced 82.12%	26,982 $1.77 Million
Q1 2020 May 13, 2020	SELL	$49.46 - $64.78 $1.37 Million - $1.8 Million	-27,730 Reduced 15.53%	150,864 $9.08 Million
Q4 2019 Feb 13, 2020	SELL	$49.86 - $58.26 $3.14 Million - $3.67 Million	-62,915 Reduced 26.05%	178,594 $10.3 Million
Q3 2019 Nov 13, 2019	SELL	$47.54 - $53.43 $8.07 Million - $9.07 Million	-169,765 Reduced 41.28%	241,509 $12.5 Million
Q2 2019 Aug 12, 2019	SELL	$46.79 - $52.47 $5.07 Million - $5.68 Million	-108,304 Reduced 20.84%	411,274 $21 Million
Q1 2019 May 13, 2019	SELL	$46.36 - $52.63 $3.65 Million - $4.14 Million	-78,690 Reduced 13.15%	519,578 $27.2 Million
Q4 2018 Feb 13, 2019	BUY	$41.54 - $47.25 $1.09 Million - $1.25 Million	26,360 Added 4.61%	598,268 $27.6 Million
Q3 2018 Nov 14, 2018	BUY	$46.76 - $51.24 $5.46 Million - $5.98 Million	116,747 Added 25.65%	571,908 $27 Million
Q2 2018 Aug 14, 2018	BUY	$44.29 - $50.42 $3.31 Million - $3.77 Million	74,787 Added 19.66%	455,161 $21 Million
Q1 2018 May 15, 2018	SELL	$48.49 - $58.14 $1.7 Million - $2.03 Million	-34,962 Reduced 8.42%	380,374 $18.7 Million
Q4 2017 Feb 09, 2018	BUY	$47.53 - $53.73 $9.28 Million - $10.5 Million	195,151 Added 88.63%	415,336 $22.3 Million
Q3 2017 Nov 13, 2017	BUY	$41.15 - $49.22 $9.06 Million - $10.8 Million	220,185	220,185 $10.6 Million

Others Institutions Holding NVO

# of Institutions

1,759

Shares Held

338M

Call Options Held

11M

Put Options Held

15.9M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $122B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Capital Fund Management S.A. with notifications on news.

Account

Capital Fund Management S.A. Novo Nordisk A S Transaction History